Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2022 Oct 18;66(11):e01304-22. doi: 10.1128/aac.01304-22

Erratum for Brown-Elliott and Wallace, “In Vitro Susceptibility Testing of Eravacycline against Nontuberculous Mycobacteria”

Barbara A Brown-Elliott , Richard J Wallace Jr
PMCID: PMC9664839  PMID: 36255269

ERRATUM

Volume 66, no. 9, e00689-22, 2022, https://doi.org/10.1128/aac.00689-22. Page 4: the second sentence of the last paragraph of Results should read “The Clinical and Laboratory Standards Institute (CLSI) acceptable range of MICs for both Staphylococcus aureus ATCC 29213 and Escherichia coli ATCC 25922 was 0.016 to 0.12 μg/mL with eravacycline.”


Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES